Substipharm is a privately held pharmaceutical Group.
We develop, supply and commercialize pharmaceuticals in more than 90 countries worldwide. Our portfolio of products that we currently license out or distribute directly or through partners comprises more than 90 different molecules. Our development pipeline includes as well more than 50 ongoing projects.
We have a successful portfolio of pharmaceutical products and vaccines including:
Mature brands
Generics
Over the counter (OTC) pharmaceuticals
Difficult to develop medicines
Value added presentations
Biological products including vaccines:
Company Details
- Employees
- 139
- Founded
- -
- Address
- 24, Rue Erlanger, Paris,île-De-France 75016,france
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.substipharm.com
- HQ
- Paris, Île-de-France
Substipharm Questions
Substipharm's website is http://www.substipharm.com
Substipharm's LinkedIn profile is https://fr.linkedin.com/company/groupsubstipharm
Substipharm has
139 employees.
View email and phone details for 139
employees at Substipharm.
Substipharm's industry is
Pharmaceutical Manufacturing
Substipharm's top competitors are
Vygoris Limited,
Amlis,
Astreapharma,
Athena Pharmaceutiques S.a.s.,
Merus Labs,
Serb Pharmaceuticals,
Delpharm,
Vectans Pharma,
Ethypharm,
Medipha Sante.
Substipharm's categories are Pharmaceutical Manufacturing
Substipharm's founding year is 1995
